News & Press Releases
Filter by:
Mintz announced today that 42 of its practices and 83 of its attorneys earned recognition in the 2024 edition of Chambers USA, a guide to the country’s leading law firms. Of those included in the guide, 18 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm obtained new listings in three practice areas and 10 of its lawyers were recognized for the first time.
Daily Journal Names Mintz Member Siegmund Gutman a 2024 ‘Top Intellectual Property Lawyer’
May 29, 2024
The Daily Journal recently named Mintz Member Siegmund "Sige" Gutman, Life Sciences Litigation Chair and Patent Litigation Co-chair, to its list of “Top Intellectual Property Lawyers” for 2024.
Mintz’s Danny Guggenheim Named A Commercial Real Estate Visionary By LA Times For Fourth Consecutive Year
May 23, 2024
LOS ANGELES - Mintz is pleased to announce that Real Estate Co-chair Danny Guggenheim has been named in The Los Angeles Times B2B Publishing’s “Commercial Real Estate: Updates, Trends & Visionaries” magazine for the fourth consecutive year. The magazine recognizes top CRE executives, dealmakers, and advisors within the commercial real estate sector and covers trends, profiles, and overall business updates. The honorees were nominated by readers for their successes and accomplishments, as well as their exemplary leadership within their organizations and communities across Southern California.
A Mintz team led by Richard Gervase, Member and Chair of the firm’s Royalty & Revenue Interest Financing Transactions Group, advised global investment firm Sixth Street in a non-dilutive, senior secured credit facility of up to $475 million for Apellis Pharmaceuticals. Apellis received $375 million in funding at close, with ability to access an additional $100 million under the facility at the Company’s option prior to September 2025, subject to the satisfaction of certain conditions.
